sulforaphane has been researched along with Fra(X) Syndrome in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napoli, E | 1 |
| Flores, A | 1 |
| Mansuri, Y | 1 |
| Hagerman, RJ | 1 |
| Giulivi, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers[NCT05233579] | 15 participants (Actual) | Interventional | 2021-06-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for sulforaphane and Fra(X) Syndrome
| Article | Year |
|---|---|
Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.
Topics: Aged; Aged, 80 and over; Ataxia; Energy Metabolism; Female; Fibroblasts; Fragile X Syndrome; Humans; | 2021 |